Oster G
Policy Analysis Inc., Brookline, MA 02146.
Am J Hosp Pharm. 1988 Mar;45(3):543-7.
An overview of the techniques of cost-effectiveness analysis as they apply to clinical decision making is presented, and ways that the techniques can assist decision makers in a limited-resource environment are identified. Most applications of cost-effectiveness analysis concern a problem in which a choice must be made between different ways of accomplishing a given clinical goal, such as treating a particular illness. As such, these applications involve comparisons between competing and mutually exclusive strategies and attempt to identify those strategies that provide the greatest benefit for a given set of resource constraints. The need for these analyses continues to increase as a consequence of the growing importance of rate-based and capitated (as opposed to cost-based) methods of paying for patient care. Despite this growing need, most decision makers will not want or be able to conduct such analyses on a regular basis; they may nonetheless benefit from formal studies of clinical problems conducted and reported by others. The validity and quality of these reports, however, need to be carefully assessed before decisions can be based on such information. Properly done, cost-effectiveness analyses can be powerful tools in clinical decision making, particularly as the concern with providing quality care in a cost-constrained environment continues to grow.
本文介绍了成本效益分析技术在临床决策中的应用概况,并确定了这些技术在资源有限环境中协助决策者的方式。成本效益分析的大多数应用都涉及一个问题,即在实现给定临床目标(如治疗特定疾病)的不同方法之间做出选择。因此,这些应用涉及相互竞争且相互排斥的策略之间的比较,并试图确定在给定资源限制下能提供最大效益的策略。由于基于费率和按人头付费(而非基于成本)的患者护理支付方式日益重要,对这些分析的需求持续增加。尽管需求不断增长,但大多数决策者不会希望或能够定期进行此类分析;不过,他们可能会从他人进行并报告的临床问题正式研究中受益。然而,在基于此类信息做出决策之前,需要仔细评估这些报告的有效性和质量。如果操作得当,成本效益分析可以成为临床决策中的有力工具,尤其是在成本受限环境中对提供优质护理的关注持续增加的情况下。